Published in Arterioscler Thromb Vasc Biol on February 01, 1998
Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats. J Mol Cell Cardiol (2013) 1.49
Integrated physiology and systems biology of PPARα. Mol Metab (2014) 1.12
Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome. PPAR Res (2007) 0.92
The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling. BMC Genomics (2013) 0.88
Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem J (2002) 0.88
Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. Environ Health Perspect (1999) 0.87
RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart. Br J Pharmacol (2003) 0.87
Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha. PPAR Res (2006) 0.81
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models. Diabetol Metab Syndr (2014) 0.76
Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling. J Clin Med (2014) 0.75
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (1992) 6.69
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 6.52
LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev (1995) 4.93
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev (1992) 4.69
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J (1996) 4.11
Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci U S A (1992) 2.85
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (1994) 2.43
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature (1997) 2.12
Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res (1997) 1.96
Transgenic mice with inducible dwarfism. Nature (1989) 1.84
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem (1995) 1.83
Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc Natl Acad Sci U S A (1993) 1.81
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A (2001) 1.74
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J Med Chem (1994) 1.68
The comparative pathobiology of alpha 2u-globulin nephropathy. Toxicol Appl Pharmacol (1989) 1.52
Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc Natl Acad Sci U S A (1995) 1.44
Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science (1983) 1.44
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. J Biol Chem (1993) 1.38
Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ (1998) 1.30
Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci U S A (1997) 1.29
Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature (1996) 1.25
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. Cancer Res (1996) 1.25
Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function. Mol Cell Biol (1998) 1.25
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol (1994) 1.24
Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest (1993) 1.24
Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell (1996) 1.21
Retinoid-X receptor signalling in the developing spinal cord. Nature (1998) 1.21
Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord (2004) 1.19
Regulation of cyclic GMP metabolism in toad photoreceptors. Definition of the metabolic events subserving photoexcited and attenuated states. J Biol Chem (1988) 1.17
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol (2001) 1.17
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med (1985) 1.15
Light-induced increases in cGMP metabolic flux correspond with electrical responses of photoreceptors. J Biol Chem (1986) 1.12
Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther (1990) 1.12
A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol (2000) 1.11
Novel retinoic acid receptor ligands in Xenopus embryos. Proc Natl Acad Sci U S A (1996) 1.10
Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem (1996) 1.10
Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res (1997) 1.07
Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol Endocrinol (1996) 1.07
Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol (1995) 1.05
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol (1995) 1.05
Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol (1995) 1.04
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res (2000) 1.04
Angiostatin suppresses malignant glioma growth in vivo. Cancer Res (1998) 1.02
Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.02
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol Pharmacol (2001) 1.02
Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia (2001) 1.00
Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle. J Biol Chem (1990) 0.98
Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells. J Med Chem (1999) 0.96
Sequence of an active fragment of B. polymyxa beta amylase. Nucleic Acids Res (1987) 0.96
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. J Med Chem (1994) 0.96
Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol (1997) 0.96
Adenosine triphosphate utilization rates and metabolic pool sizes in intact cells measured by transfer of 18O from water. Biophys J (1989) 0.95
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Res (1998) 0.95
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem Biol (1999) 0.94
Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem Suppl (1995) 0.94
Identification of the first retinoid X, receptor homodimer antagonist. J Med Chem (1996) 0.92
Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized. J Biol Chem (1985) 0.92
Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Am J Physiol (1983) 0.90
A chimeric thyroid hormone receptor constitutively bound to DNA requires retinoid X receptor for hormone-dependent transcriptional activation in yeast. Mol Endocrinol (1994) 0.90
The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol (2001) 0.89
Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol (1996) 0.89
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res (1992) 0.89
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. J Clin Invest (1985) 0.88
Teaching memory strategies to persons with multiple sclerosis. J Rehabil Res Dev (1998) 0.88
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Int J Obes (Lond) (2009) 0.88
The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res Treat (1996) 0.87
Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase. Biochim Biophys Acta (1986) 0.87
2,2,4-Trimethylpentane-induced nephrotoxicity. II. The reversible binding of a TMP metabolite to a renal protein fraction containing alpha 2u-globulin. Toxicol Appl Pharmacol (1987) 0.87
Immunological effects of insulin-like growth factor-I--enhancement of immunoglobulin synthesis. Clin Exp Immunol (1994) 0.86
Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem (1995) 0.86
Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol Cell Biol (1999) 0.84
2,2,4-Trimethylpentane-induced nephrotoxicity. I. Metabolic disposition of TMP in male and female Fischer 344 rats. Toxicol Appl Pharmacol (1987) 0.84
Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol (1996) 0.84
Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes (1988) 0.84
Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold technique. Biochim Biophys Acta (1988) 0.84
delta-Aminolevulinic acid synthetase from rat liver mitochondria. Purification and properties. J Biol Chem (1979) 0.83
Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure. J Natl Cancer Inst (1999) 0.83
Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat. Metabolism (2001) 0.83
Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency. Metabolism (1985) 0.83
Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver. Lab Invest (1986) 0.82
Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leuk Res (1996) 0.82
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res (1996) 0.82
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J Med Chem (2003) 0.82
Detection and regulation of delta-aminolevulinic acid synthetase activity in the rat brain. Arch Biochem Biophys (1978) 0.81
Analysis of CAG repeat of the Machado-Joseph gene in human, chimpanzee and monkey populations: a variant nucleotide is associated with the number of CAG repeats. Hum Mol Genet (1996) 0.81
V region dependent selection of persistent resting peripheral B cells in normal mice. Int Immunol (1993) 0.81
Involvement of reversible binding to alpha 2u-globulin in 1,4-dichlorobenzene-induced nephrotoxicity. Toxicol Appl Pharmacol (1989) 0.81
Three amino acids specify coactivator choice by retinoid X receptors. Mol Endocrinol (2000) 0.80
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. Cancer Res (1997) 0.80